Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0033-0620(89)90029-7 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Is the topical application of sesame oil (Sesamum indicum L.) combined with standard care valuable and safe for managing infusion-related phlebitis: Evidence from a systematic review with meta-analysis of randomized controlled trials.
Complement Ther Med
December 2024
Department of Operating Room Nursing, Abadan University of Medical Sciences, Abadan, Iran. Electronic address:
Article Synopsis
- The review analyzed randomized controlled trials (RCTs) to evaluate the effectiveness of topical sesame oil (SO) in preventing and managing infusion-related phlebitis (IRP), revealing inconsistent results in prior studies.
- Eight studies, covering various patients with chemotherapy and amiodarone-induced phlebitis, showed that combining standard care with SO significantly reduced IRP symptoms compared to control treatments.
- While the findings suggest that SO may positively impact IRP management, the quality of the evidence was moderate and highlighted the need for better study design and safety verification of sesame oil.
Efficacy of Self-Formulated Ergan Tang on Paroxysmal Atrial Fibrillation in Elderly Patients with Qi-Yin Deficiency: Impact on Inflammatory Marker Levels.
J Inflamm Res
December 2024
Department of Cardiology, Beijing Hepingli Hospital, Beijing, 100013, People's Republic of China.
Article Synopsis
- The study evaluates the effectiveness of a self-formulated herbal remedy, Ergan Tang, in treating paroxysmal atrial fibrillation (AF) in elderly patients with a specific deficiency type.
- Participants (40 elderly patients) were divided into two groups, receiving either Ergan Tang or the drug amiodarone, with their conditions assessed over an 8-week treatment period.
- Results showed that while both treatments had similar outcomes in the long run, the Ergan Tang group experienced significant improvements in their symptoms, a notable reduction in AF burden, decreased inflammatory markers, and a reduction in heart rate.
Efficacy and Safety of Amiodarone and Propranolol in Pediatric Cardiology for Arrhythmia After Cardiac Surgery: A Retrospective Design Study.
Cureus
November 2024
Cardiac Surgery, Jordanian Royal Medical Services, Amman, JOR.
Objectives The study evaluated the efficacy of antiarrhythmic pharmacotherapies in managing tachyarrhythmia episodes in pediatric patients with congenital heart diseases post-tricuspid valve repair, assessing reductions in haemodynamic parameters and symptomatic variables, and observing side effects. Methods From January 2020 to January 2024, this study reviewed data from 300 patients, aged up to 18 years, who experienced arrhythmia following cardiac surgery and received treatment with amiodarone, propranolol, or both. The information included demographic and anthropometric measures, haemodynamic parameters, and antiarrhythmic drugs used to treat arrhythmias before and after tricuspid valve repair.
View Article and Find Full Text PDFEfficacy and safety of different antiarrhythmic protocols used for rate control in dogs with secondary atrial fibrillation.
J Vet Cardiol
November 2024
Department of Animal Medicine, Production and Health, University of Padova, Viale dell'Università 16, 35020, Legnaro, Italy.
Introduction/objectives: Studies comparing the effects of antiarrhythmic protocols used for rate control in dogs with secondary atrial fibrillation (AF) are currently limited; therefore, this study aimed to report detailed data on the efficacy and therapy-related side-effects (TRSEs) of different antiarrhythmic protocols in dogs with secondary AF.
Animals, Materials, And Methods: Dogs with secondary AF treated with combination therapy with diltiazem and digoxin (CT), diltiazem monotherapy (MT), digoxin monotherapy (MT), or amiodarone monotherapy (MT) were retrospectively evaluated. Signalment, clinical, diagnostic, therapeutic, and outcome data were retrieved.
Cardioversion versus ablation versus 'pace and ablate' for persistent atrial fibrillation in older patients.
Br J Cardiol
April 2024
Cardiology Clinical Research Fellow King's College London, St. Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH.
Our objective was to compare the efficacy of atrial fibrillation (AF) ablation versus permanent pacemaker (PPM) with atrioventricular node ablation (AVNA) versus direct current cardioversion (DCCV) for persistent AF in patients ≥65 years old. Seventy-seven patients (aged 66-86, mean 75.4 years) with persistent AF were randomised (1:1:1) to AF ablation + amiodarone (± DCCV), PPM with AVNA (+DCCV) or DCCV + amiodarone.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!